These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 236102)

  • 1. An automated technique for the analysis of plasma guanidino acids, and some findings in chronic renal disease.
    Shainkin R; Berkenstadt Y; Giat Y; Berlyne GM
    Clin Chim Acta; 1975 Apr; 60(1):45-50. PubMed ID: 236102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guanidino compounds in uraemic dialysed patients.
    De Deyn P; Marescau B; Lornoy W; Becaus I; Lowenthal A
    Clin Chim Acta; 1986 Jun; 157(2):143-50. PubMed ID: 3719996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum guanidino compound levels in uremic pediatric patients treated with hemodialysis or continuous cycle peritoneal dialysis. Correlations between nerve conduction velocities and altered guanidino compound concentrations.
    De Deyn PP; Robitaille P; Vanasse M; Qureshi IA; Marescau B
    Nephron; 1995; 69(4):411-7. PubMed ID: 7777105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic renal failure and guanidino compounds].
    Kinoshita T
    Yakugaku Zasshi; 1997 Nov; 117(10-11):673-80. PubMed ID: 9414581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentrations in serum and urinary excretion of guanidine, 1-methylguanidine, and 1,1-dimethylguanidine in chronic renal failure.
    Stein IM; Micklus MJ
    Clin Chem; 1973 Jun; 19(6):583-5. PubMed ID: 4705174
    [No Abstract]   [Full Text] [Related]  

  • 6. Ion-exchange chromatographic separation and fluorometric detection of guanidino compounds in physiologic fluids.
    Yamamoto Y; Manji T; Saito A; Maeda K; Ohta K
    J Chromatogr; 1979 Mar; 162(3):327-40. PubMed ID: 43330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automatic system for the assay of guanidino compounds to assess uremic status and effect of hemodialysis.
    Nohara Y; Hanai T; Suzuki J; Matsumoto G; Iinuma F; Kubo H; Kinoshita T
    Chem Pharm Bull (Tokyo); 1998 Nov; 46(11):1844-5. PubMed ID: 9845964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum guanidino compound levels and clearances in uremic patients treated with continuous ambulatory peritoneal dialysis.
    De Deyn PP; Marescau B; Swartz RD; Hogaerth R; Possemiers I; Lowenthal A
    Nephron; 1990; 54(4):307-12. PubMed ID: 2325795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid-chromatographic determination of guanidino compounds in plasma and erythrocyte of normal persons and uremic patients.
    Kikuchi T; Orita Y; Ando A; Mikami H; Fujii M; Okada A; Abe H
    Clin Chem; 1981 Nov; 27(11):1899-902. PubMed ID: 7296840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of 72% injury in one kidney on several organs involved in guanidino compound metabolism: a time course study.
    Levillain O; Marescau B; Possemiers I; Al Banchaabouchi M; De Deyn PP
    Pflugers Arch; 2001 Jul; 442(4):558-69. PubMed ID: 11510889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Guanidino-succinic acid in uremic patients treated with periodic hemodialysis].
    Man NK; Rondon-Nucete M; Kamoun PP; Pleau JM; Zingraff J; Jungers P
    J Urol Nephrol (Paris); 1972 Sep; 78(9):750-5. PubMed ID: 4660657
    [No Abstract]   [Full Text] [Related]  

  • 12. Improved Gas Chromatographic Determination of Guanidino Compounds Using Isovaleroylacetone and Ethyl Chloroformate as Derivatizing Reagents.
    Zounr RA; Khuhawar MY; Jahangir TM; Alamgir M
    Anal Sci; 2016; 32(2):141-6. PubMed ID: 26860556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma, urinary, and erythrocyte concentrations of guanidino compounds in patients with chronic renal failure.
    Tanaka A; Takahashi Y; Mizokuchi M; Shimada N; Koide H
    Ren Fail; 1999 Sep; 21(5):499-514. PubMed ID: 10516995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guanidino compounds in serum and urine of nondialyzed patients with chronic renal insufficiency.
    Marescau B; Nagels G; Possemiers I; De Broe ME; Becaus I; Billiouw JM; Lornoy W; De Deyn PP
    Metabolism; 1997 Sep; 46(9):1024-31. PubMed ID: 9284891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum guanidino compound levels and the influence of a single hemodialysis in uremic patients undergoing maintenance hemodialysis.
    De Deyn P; Marescau B; Lornoy W; Becaus I; Van Leuven I; Van Gorp L; Lowenthal A
    Nephron; 1987; 45(4):291-5. PubMed ID: 3587469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Platelet aggregation in chronic renal failure--whole blood aggregation and effect of guanidino compounds].
    Maejima M; Takahashi S; Hatano M
    Nihon Jinzo Gakkai Shi; 1991 Feb; 33(2):201-12. PubMed ID: 2051648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of guanidino compounds in non-dialyzed patients with chronic renal failure.
    Ikezaki N
    Nihon Jinzo Gakkai Shi; 1990 Mar; 32(3):283-90. PubMed ID: 2355664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for the role of active oxygen in guanidine synthesis in haemodialysis patients and in vitro.
    Nagase S; Aoyagi K; Sakamoto M; Narita M; Tojo S
    Nephrol Dial Transplant; 1988; 3(6):790-4. PubMed ID: 3147421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cation-exchange chromatography of guanidine derivatives in plasma of patients with chronic renal failure.
    Perez G; Rey A; Micklus M; Stein I
    Clin Chem; 1976 Feb; 22(2):240-2. PubMed ID: 1248127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guanidino compounds after creatine supplementation in renal failure patients and their relation to inflammatory status.
    Taes YE; Marescau B; De Vriese A; De Deyn PP; Schepers E; Vanholder R; Delanghe JR
    Nephrol Dial Transplant; 2008 Apr; 23(4):1330-5. PubMed ID: 18048424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.